Lina M. Khan. Under Khan, the FTC opposed Illumina’s (NASDAQ: ILMN) acquisition of cancer blood test developer GRAIL (NASDAQ: ...

An Oxford-educated antitrust lawyer who advised the first Trump White House on technology policy is helping the president-elect pick Lina Khan’s replacement.

Healthcare investors are desperate for big returns in a second Trump term. But his health policy proposals are making them ...

A palpable buzz has taken hold of corporate boardrooms that another four years of the Republican will free up dealmaking.

Tech executives were upbeat about Donald Trump’s win this week, after an industrywide shift toward more pragmatic politics.

In the wake of the reelection of Donald Trump, some of the richest people in the world saw their net worths soar as stock prices rapidly shot up. “What ...

Donald Trump has begun the process of choosing a cabinet and selecting other high-ranking administration officials following ...

When Donald Trump is inaugurated as president for the second time in January 2025, he will assume power over the regulation of a tech industry that’s changed significantly since his first term began ...

Biden antitrust enforcers sought to discourage all mergers. The new Trump Administration should revive a prior approach that ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

Donald Trump will inherit a Biden administration legacy of aggressive antitrust enforcement through two U.S. agencies.